Author: Editor

[ad_1] Check out the companies making headlines before the bell: Insmed — Shares surged more than 26%. The global biopharmaceutical company announced positive results Tuesday from a Phase 2b study of treprostinil palmitil inhalation powder, a once-daily treatment for pulmonary arterial hypertension. J.M. Smucker —...

Call Us Now
WhatsApp